Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Journal of Immunology Publishes Study of Cleveland BioLabs' Drug CBLB502 in ... - Stock Markets Review |
 |
 |
|
Stock Markets Review Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that a study demonstrating CBLB502's ability to inhibit acute renal ischemic failure was published in the October 1, 2011 issue of The Journal of Immunology (J Immunol 2011 187:3831-3839; |
